NCT03740165 2025-10-22KEYLYNK-001Merck Sharp & Dohme LLCPhase 3 Active not recruiting1,367 enrolled 29 charts
NCT03348150 2025-07-17PERISCOPEIIThe Netherlands Cancer InstitutePhase 3 Active not recruiting102 enrolled
NCT05257408 2025-04-16Relacorilant in Combination With Nab-Paclitaxel in Advanced, Platinum-Resistant, High-Grade Epithelial Ovarian, Primary Peritoneal, or Fallopian-Tube CancerCorcept TherapeuticsPhase 3 Active not recruiting381 enrolled